3 results
The primary objective of the study is to descriptively characterize the single-dose and steadystatePharmacokinetics (PK) of diacerein (if quantifiable) and its active metabolite, rhein, after topical application of CCP-020 (diacerein 1% ointment)…
Primary Objective: to investigate if INPW will reduce wound complications such as wound dehiscence, wound infection (SSI), seroma leak and wound necrosis after arterial vascular surgery.Secondary Objective(s): to investigate if INPWT will prevent…
The primary objective of this study is to evaluate the long-term safety and tolerability of Diacerein 1% Ointment for 2 treatment cycles in subjects with EBS that were previously enrolled in studies CCP-020-301 or CCP-020-101.